- Home
- NBY vs XAIR Comparison
NBY vs XAIR Comparison
Compare NBY & XAIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBY
- XAIR
- Stock Information
- Founded
- NBY 2000
- XAIR 2011
- Country
- NBY United States
- XAIR United States
- Employees
- NBY N/A
- XAIR N/A
- Industry
- NBY
- XAIR Medical/Dental Instruments
- Sector
- NBY
- XAIR Health Care
- Exchange
- NBY Nasdaq
- XAIR Nasdaq
- Market Cap
- NBY 15.7M
- XAIR 17.0M
- IPO Year
- NBY 2007
- XAIR N/A
- Fundamental
- Price
- NBY $2.74
- XAIR $2.43
- Analyst Decision
- NBY Strong Buy
- XAIR Strong Buy
- Analyst Count
- NBY 1
- XAIR 1
- Target Price
- NBY $0.85
- XAIR $11.00
- AVG Volume (30 Days)
- NBY 21.4M
- XAIR 8.8M
- Earning Date
- NBY 11-06-2025
- XAIR 11-10-2025
- Dividend Yield
- NBY N/A
- XAIR N/A
- EPS Growth
- NBY N/A
- XAIR N/A
- EPS
- NBY 0.41
- XAIR N/A
- Revenue
- NBY $9,781,000.00
- XAIR $4,782,000.00
- Revenue This Year
- NBY $23.91
- XAIR $265.24
- Revenue Next Year
- NBY $32.05
- XAIR $136.17
- P/E Ratio
- NBY $8.11
- XAIR N/A
- Revenue Growth
- NBY 113.47
- XAIR 168.20
- 52 Week Low
- NBY $0.46
- XAIR $2.02
- 52 Week High
- NBY $4.44
- XAIR $13.52
- Technical
- Relative Strength Index (RSI)
- NBY 60.21
- XAIR 48.32
- Support Level
- NBY $2.28
- XAIR $2.13
- Resistance Level
- NBY $3.12
- XAIR $4.78
- Average True Range (ATR)
- NBY 0.63
- XAIR 0.33
- MACD
- NBY 0.02
- XAIR 0.05
- Stochastic Oscillator
- NBY 52.34
- XAIR 11.82
About NBY NovaBay Pharmaceuticals Inc.
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.
About XAIR Beyond Air Inc.
Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.